Neurophet

Neurophet EPS

The Earnings per Share (EPS) of Neurophet (380550.KQ) as of Oct 16, 2026 is -1,851.59 KRW. In the previous year, Earnings per Share (EPS) was -1,315.91 KRW — a change of 40.71% (lower).

EPS

-1,851.59KRW

YoY

40.71%

Last updated:

Earnings per Share (EPS) of Neurophet is 2025 -1,851.59 KRW. Earnings per Share (EPS) of Neurophet was 2024 -1,315.91 KRW. It decreases by 40.71% lower compared to the previous year.

The Neurophet EPS history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EPS
Date
EPS
Jan 1, 2022
-1,596.77 KRW
Jan 1, 2023
458.62 KRW
Jan 1, 2024
-1,315.91 KRW
Jan 1, 2025
-1,851.59 KRW
The Neurophet EPS history
YEAREPSYoY
-1,851.59KRW+40.71%
-1,315.91KRW-386.93%
458.62KRW-128.72%
-1,596.77KRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Neurophet Stock analysis

What does Neurophet do? Neurophet Inc is a South Korean company operating in the Health Care sector, headquartered in Seoul. The company has 135 employees and is listed on the Korean stock exchange with the ticker 380550.KQ and ISIN KR7380550004. Neurophet Inc went public on July 25, 2025, marking its initial public offering. The company focuses on the research, development, and sales of brain imaging analysis software, including PET image quantitative analysis software called 'Neurophet SCALE PET' and neurodegenerative brain disease diagnosis support software named 'Neurophet AQUA'. Additionally, Neurophet Inc develops and sells therapeutic medical devices and provides medical artificial intelligence solutions. The company's website is https://www.neurophet.com/. Neurophet Inc operates within the Health Care Technology industry, specializing in software and AI-driven tools for medical imaging and diagnostics. The company's products are designed to support healthcare professionals in analyzing brain imaging data and diagnosing neurological conditions. As a technology-focused health care provider, Neurophet Inc aims to enhance diagnostic accuracy and efficiency through its software solutions. The company's operations are based in Seoul, South Korea, and it is engaged in both the development and commercialization of its medical technology products. Neurophet Inc's business model centers on creating innovative software tools that address specific challenges in neurology and brain imaging analysis. Neurophet is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Neurophet stock

Earnings per Share (EPS) of Neurophet is -1,851.59 KRW in 2025.

Earnings per Share (EPS) of Neurophet changed from -1,315.91 KRW to -1,851.59 KRW, representing a 40.71% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Earnings per Share (EPS) Neurophet since 2006 – with annual values, charts, and detailed analysis.

Earnings per Share measures the portion of a company's profit allocated to each outstanding share. It is a key metric for assessing a company's profitability on a per-share basis.

EPS = Net Income / Shares Outstanding

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Neurophet

All Key Metrics — Neurophet